Evaluation of the effect of Onosma bracteatum, wall (Boraginaceae)) using experimental allergic and inflammatory models

Global Journal of Pharmacology

Volumn 5, Issue 1, 2011, Pages 40-49

  Patel, Kalpana G ^a   Detroja, Jaysukh R ^a   Shah, Tanmay A ^a   Patel, Kirti V ^a   Gandhi, Tejal R ^a  

^a ANAND PHARMACY COLLEGE   (India)

Author keywords

Allergy; IgE; Inflammation; Mast cell; Onosma bracteatum; Vascular permeability

Indexed keywords

ALCOHOL; ANTIALLERGIC AGENT; ANTIINFLAMMATORY AGENT; CROMOGLYCATE DISODIUM; DEXAMETHASONE; DICLOFENAC; INDOMETACIN; KETOTIFEN; ONOSMA BRACTEATUM EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIALLERGIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BORAGINACEAE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; EOSINOPHIL COUNT; FEMALE; MALE; MOUSE; NONHUMAN; ONOSMA BRACTEATUM; PASSIVE SKIN ANAPHYLAXIS; PAW EDEMA; PLEURISY; RAT; SKIN ANAPHYLAXIS;

EID: 79957636729     PISSN: 19920075     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Pride, N.B., 1992. Definition and clinical spectrum, Asthma. In: P.J. Barnes, (eds). Br. Med. Bull., 48: 1-9.
2. Jeffery, P.K., 1992. Pathology of asthma, Asthma. In: P.J. Barnes, ed. Br. Med. Bull., 48: 23-39.
3. Wills-Karp, M., J. Luyimbazi, X. Xu, B. Schofield, T.Y. Neben, C.L. Karp and D.D. Donaldson, 1998. Interleukin-13: central mediator of allergic asthma. Sci., 282: 2258-2260.
4. Nicolaides, N.C., K.J. Holroyd, S.L. Ewart, S.M. Eleff, M.B. Kiser, C.R. Dragwa, C.D. Sullivan, L. Grasso, L.Y. Zhang, C.J. Messler, T. Zhou, S.R. Kleeberger, K.H. Buetow and R.C. Levitt, 1997. Interleukin 9: a candidate gene for asthma. Proc. Natl. Acad. Sci. U.S.A., 94: 13175-13180.
5. Safwat, T., 2007. Towards a deep understanding of bronchial asthma. Egyptian J. Bronchol. 1(1): 120-124.
6. O' Byrne, P.M. and D.S. Postma, 1999. The many faces of airway inflammation - Asthma and Chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med., 159: S41-S66.
7. Giembycz, M.A., 2000. Phosphodiesterase 4 inhibitors and the treatment of asthma- where are we now and where do we go from here. Drugs, 59: 193-212.
8. Barnes, P.J. and S. Pederson, 1993. Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, October 1992. Am. Rev. Respir. Dis., 148: S1-S26.
9. Salib, R.J., A. Drake Lee and P.H. Howarth, 2003. Allergic rhinitis: past, present and the future. Clin. Otolaryngol., 28: 291-303.
10. Kirtikar, K.R. and B.D. Basu, 1999. Indian Medicinal Plants, second edition, Volume III, International Book Distributors, pp: 1699.
11. rd revised edition, Volume I, Popular Prakashan Pvt. Ltd., Bombay, India, pp: 871.
12. Patel, K.G., K.V. Patel and T.R. Gandhi, 2008. Evaluation of the effect of Onosma bracteatum Wall (Boraginaceae) on bronchial hyperreactivity in sensitized guinea pigs. Iran. J. Pharmacol. and Thera, 7(1): 35-41.
13. th edition, Oxford, Blackwell Science.
14. Busse, W.W., W.F. Calhoun and J.D. Sedgwick, 1993. Mechanism of airway inflammation in asthma. Am. Rev. Respir. Dis., 147: 520-524.
15. Corrigan, C.J. and A.B. Kay, 1992. T-cell and eosinophils in the pathogenesis of asthma. Immunol. Today, 13(2): 501-7.
16. Kline, J.N. and G.W. Hunninghake, 1994. T-lymphocyte dysregulation in asthma. Proc. Soc. Exp. Biol. Med., 207(3): 243-253.
17. Poulter, L.W., D.G. Janossy and C. Power, 1994. Immunological/ Physiological relationships in asthma: Potential regulation by lung macrophages. Immunol. Today, 15(6): 258-261.
18. Sipteri, M.A. and L.W. Poulter, 1991. Characterization of immune inducer and suppressor macrophage from normal human lung. Clin. Exp. Immunol., 83: 157-162.
19. Barnes, P.J. and F.V. Liew, 1991. Nitric oxide and asthmatic inflammation. Immunol. Today, 16(3): 128-130.
20. Najam, F.I.E., A.S.M. Giasuddin and A.H. Shembesh, 2001. Tumour necrosis factors in childhood Asthma. Indian J. Pediatr., 68(3): 217-222.
21. Najam, F.I.E., A. S.M. Giasuddin and A.H. Shembesh, 1999. Immunoglobulin isotypes in childhood asthma. Indian J. Pediatr., 66(3): 337-344.
22. Lee, K.S., S.R. Kim, H.S. Park, G.Y. Jin and Y.C. Lee, 2004. Cysteinyl leukotriene receptor antagonist regulates vascular permeability by reducing vascular endothelial growth factor expression. J. Allergy Clin. Immunol., 114: 1093-9.
23. Whittle, B.A., 1964. The use of changes in capillary permeability in mice to distinguish between narcotic and nonnarcotic analgesics Brit. J. Pharmacol., 22: 246-53.
24. Yesilada, E. and E. Kupeli, 2002. Berberis crataegina DC. root exhibits potent anti-inflammatory, analgesic and febrifuge effects in mice and rats J. Ethnopharmacol., 79: 237-48.
25. Harris, J.M. and P.S.J. Spencer, 1962. A modified plethysmographic apparatus for recording volume changes in rat paw. J. Pharm. Pharmacol., 14: 464-466.
26. Winter, C.A., E.A. Risley and W. Nuss, 1962. Carrageenan induced edema in hind paw of rats as an assay for anti-inflammatory drugs. Proc. Soc. Exp. Biol. Med., 111: 544-547.
27. Martel, R.R., J. Klicius and J. Pinski, 1978. Inhibition of passive anaphylaxis induced in the rat hind paw and peritoneal cavity by N-(2-oxo-3,5,7-cycloheptatrien-1-yl)-aminooxoacetic acid ethyl ester (AY-25,674): Can. J. Physiol. Pharmacol. 56(6): 1005-10.
28. Matsuda, H., Y. Dai, Y. Ido, M. Yoshikawa and M. Kubo, 1997. Studies on Kochiae Fructus IV. Anti-Allergic Effects of 70% Ethanol Extract and Its Component, Momordin Ic from Dried Fruits of Kochia scoparia L. Biol. Pharm. Bull., 20: 1165-1170.
29. Katayama, S., H. Shionoya and S. Ohtake, 1978. A new method for extraction of extravasated dye in the skin and the influence of fasting stress on passive cutaneous allergy in guinea pigs and rats. Microbiol. Immunol., 22: 89-101.
30. Sampaio, A.L., G.A. Rae and M.M. Henriques, 2000. Role of endothelins on lymphocyte accumulation in allergic pleurisy. J. Leukoc. Biol., 67: 189-195.
31. Henriques, M.G., V.B. Weg, M.A. Martins, P.M. Silva, P.D. Fernandes and R.S. Cordeiro, 1990. Differential inhibition by two hetrazepine PAF antagonists of acute inflammation in the mouse. Br. J. Pharmacol., 99: 164-168.
32. Hamano, KJ., G.J. Gleich, R.H. Gundel and S.R. White, 1991. In: The Airway Epithelium Physiology, Pathophysiology and Pharmacology, Farmer, S.G. and Hay, D.W.P., pp: 255-318.
33. Vogel, W.H., B.A. Scholkens, J. Sandow, G. Muller and W.F. Vogel, 2002. Drug discovery and evaluation, Pharmacological essays, Springer Verlag Berlin Heidelberg, New York, Second edition, pp: 725-771.
34. Miles, A. A. and E.M. Miles, 1952. Vascular reactions to histamine, histamine liberator and leukotaxine in the skin of guinea pigs. J. Physiol., 118: 228-257.
35. Persson, C.G., 1996. Epithelial cells: barrier functions and shedding restitution mechanisms. Am. J. Respir. Crit. Care Med., 153: S9-10.
36. Thurston, G., J.S. Rudge, E. Ioffe, H. Zhou, L. Ross, S.D. Croll, N. Glazer, J. Holash, D.M. McDonald and G.D. Yancopoulos, 2000. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat. Med., 6: 460-3.
37. Lee, K.S., S.R. Kim, H.S. Park, G Y. Jin and Y.C. Lee, 2004. Cysteinyl leukotriene receptor antagonist regulates vascular permeability by reducing vascular endothelial growth factor expression. J. Allergy Clin. Immunol., 114: 1093-9.
38. Lee, Y.C., Y.G. Kwak and C.H. Song, 2002. Contribution of vascular endothelial growth factor to airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma. J. Immunol., 168: 3595-600.
39. Dai, Y., Y.P. Chan, L.M. Chu and P.P.H. But, 2002. Antiallergic and Anti-inflammatory Properties of the Ethanolic Extract from Gleditsia sinensis. Biol. Pharm. Bull., 25(9): 1179-1182.
40. Vinegar, R., W. Schreiber and R. Hugo, 1969. Biphasic development of carrageenan edema in rats. J. Pharmacol. Exp. Therapeutics, 166: 96-103.
41. Kim, D.Y. and M. Camilleri, 2000. Serotonin: a mediator of the brain-gut connection. Am. J. Gastroenterol., 95: 2698-2709.
42. Cunha, T.M., W.A. Verri, J.S. Silva, S. Poole, F.Q. Cunha and S.H. Ferreira, 2005. A cascade of cytokines mediated mechanical inflammatory hypernociception in mice. Proc. Natl. Acad. Sci. U.S.A., 105(5): 1755-1760.
43. Murray, J.F. and J.A. Nadel, 2000. Textbook of Respiratory Medicine, Volume I, Third edition, Philadelphia, Pa.: W.B. Saunders.
44. Galli, S.J., J. Kalesnikoff, M.A. Grimbaldeston, A.M. Piliponsky, C.M. Williams and M. Tsai, 2005a. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol., 23: 749-786.
45. Galli, S.J., S. Nakae and M. Tsai, 2005b. Mast cells in the development of adaptive immune responses. Nat. Immunol., 6: 135-142.
46. Kim, H.M., E.H. Lee and H.H. Cho, 1998. Inhibitory effect of mast cell-mediated immediate-type allergic reactions in rats by spirulina. Biochem. Pharmacol., 55: 1071-1076.
47. Mahajan, S.G., R.G. Mali and A.A. Mehta, 2006. Antianaphylactic and anti-inflammatory activity of hydroalcoholic extract of leaves of Moringa Oleifera. Planta Indica, 2(3): 9-12.
48. Jeong, H.J., P.D. Moon, J.Y. Um, J. Park, K.H. Leem, C.J. Kim, H.M. Kim and S.H. Hong, 2007. Effect of Gamiseunggal-Tang on immediate type allergic reaction in mice. Indian J. Med. Res., 125: 542-549.
49. Moon, P.D., H.Y. Shin, H.J. Na, H.J. Jeong, S.J. Kim, J.Y. Um, R.K. Park, H.M. Kim and S.H. Hong, 2007. Gamijeonssibaekchulsan regulates mast cell-mediated anaphylactic reaction. Acta Biochimica Polonica, 54(2): 349-355.
50. Horiuchi, M. and Y. Seyama, 2008. Improvement of the anti-inflammatory and antiallergic activity of Bidens pilosa L. var. radiate SCHERFF treated with enzyme (Cellulosine). J. Health Sci., 54(3): 294-301.
51. Azzawi, M., B. Bradley, P.K. Jeffrey, A.J. Frew, A.J. Wardlaw, G. Knowles, B. Assouf, J.V. Collins, S. Durham and A.B. Kay, 1990. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthmatics. Am. Rev. Respir. Dis., 142: 1407.
52. Bentley, A.M., Q. Meng, D.S. Robinson, Q. Humid, A.B. Kay and S.R. Durham, 1993. Increases in activated T-lymphocytes, eosinophils and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after inhalation challenge in atopic asthmatics. Am. J. Respir. Cell. Mol. Biol., 8: 835.
53. Brito, F.A., L.A. Lima, M.F.S. Ramos, M.J. Nakamura, S.C. Cavalher-Machado, A.C. Siani, M.G.M.O. Henriques and A.L.F. Sampaio, 2007. Pharmacological study of anti-allergic activity of Syzygium cumini (L.) Skeels. Braz. J. Med. Biol. Res., 40(1): 105-115.
54. Wardlaw, A.J., 1999. Molecular basis for selective eosinophil trafficking in asthma: a multistep paradigm. J. Allergy Clin. Immunol., 104: 917-926.
55. Motojima, S., E. Frigas, D.A. Loegering and G.J. Gleich, 1989. Toxicity of eosinophil cationic proteins for guinea-pig tracheal epithelium in vitro. Am. Rev. Respir. Dis., 139: 801.
56. Pretolani, M., C. I. Luffi, E. Lapa J.R. Silva, D. Joseph, R.R. Lobb and G.B.B. Vargaftig, 1994. Antibody to Very Late Activation Antigen 4 Prevents Antigen-induced Bronchial Hyperreactivity and Cellular Infiltration in the Guinea Pig Airways. J. Exp. Med., 180: 795-805.
57. Underwood, S., M. Foster, D. Raeburn, S. Bottoms and J.A. Karlsson, 1995. Time course of antigen induced airway inflammation in the guinea pig and its relationship to airway hyperresponsiveness. Eur. Respir. J., pp: 2104-2113.
58. Beasley, R., R.W. Roche, J.A. Roberts and S.T. Holgate, 1989. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am. Rev. Respir. Dis., 139: 806-817.
59. Djukanovic, R., W.R. Roche and J.W. Wilson, 1990. Mucosal inflammation in asthma. Am. Rev. Respir. Dis., 142: 434-457.
60. Underwood, S., M. Foster, D. Raeburn, S. Bottoms and J.A. Karlsson, 1995. Time course of antigen induced airway inflammation in the guinea pig and its relationship to airway hyperresponsiveness. Eur. Respir. J., pp: 2104-2113.